Not accurately. When both target GLP-1 receptors, Tirz also activates GIP receptors, rendering it a twin agonist. This broader mechanism is considered to boost its effects on insulin sensitivity and appetite signaling in investigate types. El reto farmacológico de esta clase de moléculas es el equilibrium entre las tres actividades: https://peptisell.com/product/tirzepatide